Quarterly Activity Chart
Adds vs. Reduces by Quarter
PaperPanda Equity Terminal
RYTM —
RHYTHM PHARMACEUTICALS INC
CUSIP: 76243J105 · Held by 2 superinvestors · Combined value: $56,989,702
Latest News
Loading financials…
| # | Investor | % of Portfolio | Value ($) | Shares | Recent Activity | Share Change |
|---|---|---|---|---|---|---|
| 1 | Jim Simons | 0.1% | $36,521,299 | 341,193 | REDUCE | -205,400 |
| 2 | Ken Griffin | 0.0% | $20,468,403 | 191,222 | ADD | +4,396 |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Ken Griffin | ADD | +4,396 | +2.4% |
| Jim Simons | REDUCE | -205,400 | -37.6% |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | ADD | +231,700 | +73.6% |
| Ken Griffin | ADD | +141,126 | +308.8% |
Who Owns RYTM? Superinvestor Holdings
RHYTHM PHARMACEUTICALS INC is held by 2 tracked superinvestors, with a combined position value of $57 million . The largest positions are held by Jim Simons (0.1% of portfolio), Ken Griffin (0.0% of portfolio).
In the most recent quarter, 1 superinvestor added or initiated positions while 1 reduced or exited.